Moderna (NASDAQ:MRNA) Leads U.S. Biotechs’ Plunge after FDA’s Top Vaccine Regulator Resigns
PremiumMarket NewsModerna (NASDAQ:MRNA) Leads U.S. Biotechs’ Plunge after FDA’s Top Vaccine Regulator Resigns
6d ago
Taysha Gene Therapies announces inducement grant under Nasdaq listing rule
Premium
The Fly
Taysha Gene Therapies announces inducement grant under Nasdaq listing rule
1M ago
Buy Rating Reiterated for Taysha Gene Therapies Amid Positive Clinical Data and Strong Financial Position
Premium
Ratings
Buy Rating Reiterated for Taysha Gene Therapies Amid Positive Clinical Data and Strong Financial Position
1M ago
Positive Outlook on Taysha Gene Therapies: Promising Developments and Financial Stability
PremiumRatingsPositive Outlook on Taysha Gene Therapies: Promising Developments and Financial Stability
1M ago
Taysha Gene Therapies reports FY24 EPS (36c) vs (96c) last year
Premium
The Fly
Taysha Gene Therapies reports FY24 EPS (36c) vs (96c) last year
1M ago
TSHA Earnings Report this Week: Is It a Buy, Ahead of Earnings?
Premium
Pre-Earnings
TSHA Earnings Report this Week: Is It a Buy, Ahead of Earnings?
1M ago
Taysha Gene Therapies price target raised to $8 from $6 at Canaccord
PremiumThe FlyTaysha Gene Therapies price target raised to $8 from $6 at Canaccord
5M ago
3 Best Stocks to Buy Now, 11/14/2024, According to Top Analysts 
Premium
Market News
3 Best Stocks to Buy Now, 11/14/2024, According to Top Analysts 
5M ago
Taysha Gene Therapies Advances in Rett Syndrome Trials
Premium
Company Announcements
Taysha Gene Therapies Advances in Rett Syndrome Trials
5M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100